ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Telesis Bio Inc (PK)

Telesis Bio Inc (PK) (TBIO)

0.75
0.15
(25.00%)
Closed December 02 4:00PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
0.75
Bid
0.60
Ask
1.00
Volume
3,755
0.60 Day's Range 0.91
0.25 52 Week Range 3.95
Market Cap
Previous Close
0.60
Open
0.60
Last Trade
6
@
0.806225
Last Trade Time
Financial Volume
$ 2,466
VWAP
0.656805
Average Volume (3m)
31,771
Shares Outstanding
1,775,839
Dividend Yield
-
PE Ratio
-1.81
Earnings Per Share (EPS)
-3.3
Revenue
15.2M
Net Profit
-5.85M

About Telesis Bio Inc (PK)

Sector
Lab Analytical Instruments
Industry
Lab Analytical Instruments
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
Telesis Bio Inc (PK) is listed in the Lab Analytical Instruments sector of the OTCMarkets with ticker TBIO. The last closing price for Telesis Bio (PK) was $0.60. Over the last year, Telesis Bio (PK) shares have traded in a share price range of $ 0.25 to $ 3.95.

Telesis Bio (PK) currently has 1,775,839 shares outstanding. The market capitalization of Telesis Bio (PK) is $1.07 million. Telesis Bio (PK) has a price to earnings ratio (PE ratio) of -1.81.

TBIO Latest News

Transgenomic Announces Executive Changes

Paul Kinnon Named President, Chief Executive Officer and Director

Transgenomic to Present at the Craig-Hallum 4th Annual Alpha Select Conference

Transgenomic, Inc. (OTCBB: TBIO) today announced that Craig Tuttle, Chief Executive Officer of Transgenomic, will be presenting at the Craig-Hallum Capital Group’s 2013 Alpha Select...

Quest Diagnostics Introduces Comprehensive Opioid Therapy Genetic Test Based on CYP450 Biomarker License with Transgenomic

Quest Diagnostics Introduces Comprehensive Opioid Therapy Genetic Test Based on CYP450 Biomarker License with Transgenomic Believed to be first clinical test to identify variants of four enzymes...

Transgenomic Reports Second Quarter 2013 Financial Results

Conference Call to Be Held at 5:00 PM Eastern Time Today

Reminder: Transgenomic to Hold Second Quarter Financial Results Conference Call on August 6, 2013

Transgenomic, Inc. (OTC/BB: TBIO) today announced the following Webcast:   What: Transgenomic, Inc. Second Quarter 2013 Financial Results and...

Transgenomic to Hold Second Quarter Financial Results Conference Call on August 6, 2013

Transgenomic, Inc. (OTCBB: TBIO) today announced the following Webcast:       What: Transgenomic, Inc. Second Quarter 2013 Financial...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.1-11.76470588240.850.910.622830.74437251CS
4-0.7-48.2758620691.451.50.672011.04464319CS
120.52000.253.950.25317713.10080143CS
260.52000.253.950.25297853.10080143CS
520.52000.253.950.25291773.10080143CS
1560.52000.253.950.25264763.10080143CS
2600.52000.253.950.25250823.10080143CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
KBNTKubient Inc (CE)
$ 0.0003
(29,900.00%)
400
YAYOYayYo Inc (CE)
$ 0.0002
(19,900.00%)
15.71k
NHIQNantHealth Inc (CE)
$ 0.25
(12,400.00%)
1.12k
ARDSAridis Pharmaceuticals Inc (CE)
$ 0.0001
(9,900.00%)
33.37k
NSTBNorthern Star Investment Corporation II (CE)
$ 0.01
(9,900.00%)
300
CLVRClever Leaves Holdings Inc (CE)
$ 0.0002
(-99.98%)
676
CITLFCritical Infrastructure Technologies Ltd (PK)
$ 0.0001
(-99.96%)
500
RQHTFReliq Health Technologies Inc (CE)
$ 0.000001
(-99.91%)
100
EORBFOrbite Technologies Inc (CE)
$ 0.000001
(-99.69%)
95.8k
ANTHAnthera Pharmaceuticals Inc (CE)
$ 0.000001
(-99.50%)
428
RDARRaadr Inc (PK)
$ 0.0011
(29.41%)
407.34M
CMGRClubhouse Media Group Inc (PK)
$ 0.0001
(0.00%)
304.71M
DPUIDiscount Print USA Inc (PK)
$ 0.0003
(50.00%)
187.09M
HMBLHUMBL Inc (PK)
$ 0.0003
(50.00%)
105.08M
DRNGDrone Guarder Inc (PK)
$ 0.00025
(25.00%)
88.96M

Discussion

View Full Feed
alertmeipp alertmeipp 5 minutes ago
For the nth time, hope we can move on from Crown and Foley fired.
RVNC
Real McCoy Real McCoy 5 minutes ago
They tried to recapitalize but it failed so they had no choice but to liquidate.
Welcome2Pinkyland Welcome2Pinkyland 5 minutes ago
$KRTL for the win $$
KRTL
11L1 11L1 6 minutes ago
Nov 20, 2024 https://www.sahmcapital.com/news/content/keefe-bruyette-woods-downgrades-federal-national-mortgage-to-market-perform-raises-price-target-to-3-2024-11-20
FNMA
GrandAdmiralThrawn GrandAdmiralThrawn 7 minutes ago
Getting close, My stock pick coming for January, long hold, but sorry guys, I'm looking to control most of the float. So I'll let you know in January.
DjScottyT DjScottyT 8 minutes ago
What an absolute shitshow!
TSOI
getmoreshares getmoreshares 8 minutes ago
don't mind the dips- HATE- LACK of vol!
CGAC
MDA MDA 9 minutes ago
It's the same 5 dumbasses posting.

That is called an, ECHO-CHAMBER.

You dumbass.

Clearly MJ is one too.

Consider your money gone, just like a degenerate gambler.

Me too, only $1500
RNVA
Viewmont Viewmont 10 minutes ago
Only "NO RS" will save us shareholders! Otherwise, us, me, the existing shareholders are/will be screwed big time, and we will be wiped out regardless! (Maybe that was the SANP's goal the hole time.)
I am bulish, hold lots of shares and I hugely just hope that there'll be NO RS.
SANP
XMaster2023 XMaster2023 10 minutes ago
I think you have a typo. Should be 2024 or 2025 not 2026. But it figures, you have never been good with numbers.
NWBO
patrik patrik 10 minutes ago
Agree Longrider,
The source is the problem. HAs anyone ever seen any delay, pause, missed timeline,
or silence from our leader has ever led to anything good from Kim. I can’t think
of any. With Kim at the helm no news has ever been good news. Silence is not
golden with K
KBLB
elks elks 11 minutes ago
Float. 13,295 000. Tic toc.
AZRH
JoJr JoJr 11 minutes ago
I think you're right about that.

They are seriously looking to get into the US Capital Markets and doing it the right way.
RDAR
New money98 New money98 12 minutes ago
Hmmm....is Sofinnova linked to Bioamber??? Just thinking out loud..don't mind me
in99flyers in99flyers 13 minutes ago
1,446,444 holders of Shiba. Up another 1k holders in just a few hours since my last post. This is moving quicker and upward more quickly than I anticipated. Where are all of these new holders coming from? People are lined up to buy Shiba like the welfare line on the 1st and 15th. Let's go.
SHIBUSD
JoJr JoJr 14 minutes ago
Interesting...
Very interesting...

Sargent Schultz...

:)
RDAR
AstroGuru64 AstroGuru64 14 minutes ago
Keefe, Bruyette & Woods analyst Bose George downgrades Federal National Mortgage (OTC:FNMA) from Outperform to Market Perform and raises the price target from $2 to $3.
FNMA
Denisk Denisk 14 minutes ago
Yes That was Karim Mikhail biggest snafu, to go after & try to get approval from the hardest & strictest government regulated Country in all of Europe. I have no idea how much was spent there for nothing, but it must have been very costly to AMRN.
AMRN
INEEDMONEY INEEDMONEY 14 minutes ago
So what's your target here? That's a nice post /trade.
CGAC
XMaster2023 XMaster2023 16 minutes ago
He has not paid more than MUSK!
NWBO
PennyMillions852 PennyMillions852 16 minutes ago
Wow what an ongoing SHITFEST!!!!!!
THBD
jsc52033 jsc52033 18 minutes ago
what symbol do you use to find the vix I can't find it typing vix on schwab they send me into uvxy and uvix
I can't figure out which is the actual vix I'm looking for calls on it
SPY
Rodney5 Rodney5 18 minutes ago
That’s mortgage backed securities MBS’s purchased by the Treasury is exactly what Congress approved in the Charter Act amended by HERA, NOT an illegal commitment fee attached to the illegal Senior Preferred Stock SPS. The United States Treasury does not have the Authority from Congress to collect on
FNMA
12x 12x 18 minutes ago
These appear to be CHMP-requested post-hoc analyses based on pre-specified APOE types, rather than company-initiated ones conducted pre-submission. My concern is that AVXL needs to tread carefully between hypothesis generation and confirmation, especially at this critical drug approval stage. These
AVXL

Your Recent History

Delayed Upgrade Clock